PharmaControl Corp acquire Private Formulations Inc Revco D.S. Inc> six mln dlrs cash 13550000 dlr promissory note warrant buy 200000 PharmaControl common shares. PharmaControl purchase price finance mln dlrs work capital secure institutional financing. The company betweenm 11550000 dlrs 12550000 dlrs f principal amount Revco note plus accrue payable June 30. The balance payable years. PharmaControl expect payment due Revco proceeds propose offering unit consist convertible subordinate debenturers common stock currently file Securities Exchange Commission. Upon closing offering company expect secure institutional financing increase total 12 mln dlrs. Private Formulations primarily engage manufacture distribution vitamin private label over-the-counter pharmaceutical products. Reuter 